Problems associated with long-term treatment with selective serotonin reuptake inhibitors.
about
Milnacipran: a unique antidepressant?Treatment of premenstrual dysphoric disorderA pilot phase II trial of magnesium supplements to reduce menopausal hot flashes in breast cancer patients.Relationship between use of selective serotonin reuptake inhibitors and irritable bowel syndrome: A population-based cohort studyRoyal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders.Primum non nocere: an evolutionary analysis of whether antidepressants do more harm than good.ISPMD consensus on the management of premenstrual disorders.Vilazodone: in major depressive disorder.Off-label uses of trazodone: a review.The reappraisal of benzodiazepines in the treatment of anxiety and related disorders.Vilazodone: a review in major depressive disorder in adults.Long-term antidepressant use: patient perspectives of benefits and adverse effects.Unified protocol for the discontinuation of long-term serotonin reuptake inhibitors in obsessive compulsive disorder: Study protocol and methods.Effect of Agomelatine and Fluoxetine on HAM-D Score, Serum Brain-Derived Neurotrophic Factor, and Tumor Necrosis Factor-α Level in Patients With Major Depressive Disorder With Severe Depression.Women's experiences of coping with the sexual side effects of antidepressant medication.Geriatric drug utilisation of psychotropics in Belgian nursing homes.Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review.Statistically Significant Antidepressant-Placebo Differences on Subjective Symptom-Rating Scales Do Not Prove That the Drugs Work: Effect Size and Method Bias Matter!
P2860
Q24610271-C1EAB54F-FA18-40F6-A1B0-C6E861C4A9B8Q28300895-DB452AEF-B46C-42EB-B2B1-A74185F3F9F2Q30426749-F031576B-A321-40F7-B093-27881BB3679EQ33719985-3DE334FE-1E72-471E-BC2D-698FF6F6F231Q35862776-C127F7D6-E7E2-4E9C-A166-D7F80A5ECA88Q35907475-6313A04D-8B6D-4948-BB7A-6E4F8624146DQ37638987-8AC2E774-DCE5-4EAF-9F96-3251458E9FB2Q37893639-ED72CED9-A477-4598-A635-0DA87D1A98D8Q38019969-1AB0F184-9B00-4898-91F9-DF053971B216Q38252986-75E33E60-22B9-431B-9EE3-86860DA4E5D7Q38615116-CA47F09E-55E2-4518-BF3F-9187328E5BEEQ39486415-56B3F3A6-05CD-4A25-A652-AA08403F63C7Q47202780-864F3E93-B75A-490B-BDBA-B7F38E8930F0Q47790524-43B37199-2223-4435-AB7F-49758257A117Q48261299-2242C256-689C-4029-A0BC-43A77C499439Q48312802-BAEDBD6E-CA9A-44F8-93E6-E9DE4423F258Q55054440-70A413B0-1247-482A-B854-4C858DB04A33Q58606569-7439CECC-8285-4206-8517-DF6899FC014B
P2860
Problems associated with long-term treatment with selective serotonin reuptake inhibitors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Problems associated with long- ...... serotonin reuptake inhibitors.
@en
Problems associated with long- ...... serotonin reuptake inhibitors.
@nl
type
label
Problems associated with long- ...... serotonin reuptake inhibitors.
@en
Problems associated with long- ...... serotonin reuptake inhibitors.
@nl
prefLabel
Problems associated with long- ...... serotonin reuptake inhibitors.
@en
Problems associated with long- ...... serotonin reuptake inhibitors.
@nl
P2093
P2860
P356
P1476
Problems associated with long- ...... serotonin reuptake inhibitors.
@en
P2093
P2860
P304
P356
10.1177/0269881108093582
P407
P577
2008-07-17T00:00:00Z